Follow-The-Filings

Security · featured owners

ABUS Arbutus Biopharma Corp.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 exit

ABUS (Arbutus Biopharma Corp.) 13F ownership among featured managers we track as of 2026 Q2. Figures are as-filed 13F, not free float.

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
David Witzke - Avidity Partners Management exited 2026 Q2 last 2026 Q1 0.11% Exit −0.11% 125,000 $563K history

0 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $18.14M $6.17M $14.08M
Net income -$72.85M -$69.92M -$33.5M
Net margin * -401.6% -1133.0% -237.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $132.03M $127.32M $94.46M
Total non-current assets * $12.37M $4.39M $0.162M
Total assets $144.4M $131.71M $94.62M
Total current liabilities $22.49M $15.62M $6.01M
Total non-current liabilities * $15.9M $18.72M $12.04M
Total equity $106.02M $97.37M $76.58M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$85.94M -$64.85M -$39.64M
Cash from investing $50.77M $22.95M $15.58M
Cash from financing $30.65M $52M $5.72M
Net change in cash -$4.49M $10.04M -$18.32M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders